C12Y 207/07048
Rna-directed rna polymerase , i.e. rna replicase
Official title: RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
C12Y207/07048 (Rna-directed rna polymerase , i.e. rna replicase) appears on 30 US grants and 69 published applications in this corpus.
Search patents in C12Y- Granted patents
- 30
- Published applications
- 69
- Assignees
- 54
- Inventors
- 196
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 0 | 1 |
| 2015 | 1 | 3 |
| 2016 | 1 | 4 |
| 2017 | 1 | 4 |
| 2018 | 3 | 2 |
| 2019 | 5 | 2 |
| 2020 | 3 | 5 |
| 2021 | 2 | 3 |
| 2022 | 3 | 7 |
| 2023 | 2 | 4 |
| 2024 | 3 | 9 |
| 2025 | 2 | 6 |
| 2026 | 4 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered cells secreting therapeutic enzymes18 Aug 2026US 12,709,739 B2Cartesian Therapeutics, Inc.
- Replicase cycling reaction (RCR) and the related SamRNA designs thereof5 May 2026US 12,618,068 B2
- Mirror nucleic acid replication system21 Apr 2026US 12,606,808 B2Tsinghua University
- Replicase cycling reaction (RCR)31 Mar 2026US 12,590,329 B2
- Methods and compositions for prime editing RNA7 Oct 2025US 12,435,330 B2President and Fellows of Harvard College
- Artificial secoviridae satellite rnas1 Oct 2026US 2026/0297596 A1Flagship Pioneering Innovations Vii, LLC
- Artificial tombusviridae satellite rnas1 Oct 2026US 2026/0297598 A1Flagship Pioneering Innovations Vii, LLC
- Artificial tymovirales satellite rnas1 Oct 2026US 2026/0297606 A1Flagship Pioneering Innovations Vii, LLC
- Rna replicons, compositions and methods of use thereof24 Sep 2026US 2026/0286321 A1Able Sciences, Inc.
- Prime editing of single base mutations in sickle cell disease17 Sep 2026US 2026/0273102 A1Beam Therapeutics Inc.
Most cited
By later US patents
- Substituted nucleosides, nucleotides and analogs thereof25US 9,073,960 B2Alios BioPharma, Inc. · 2015
- Substituted nucleosides, nucleotides and analogs thereof24US 9,758,544 B2Alios BioPharma, Inc. · 2017
- Coronavirus20US 10,130,701 B2The Pirbright Institute · 2018
- Substituted nucleosides, nucleotides and analogs thereof12US 10,464,965 B2Alios BioPharma, Inc. · 2019
- Self-replicating cell selective gene delivery compositions, methods, and uses thereof1US 10,188,750 B1University of South Florida · 2019